Oculis Aktie 124230349 / CH1242303498
21.26
USD
-0.10
USD
-0.44 %
17:09:00
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Oculis Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Oculis Holding AG | 0.00 | 0.00 | USD |
| 2023 | Oculis Holding AG | 0.00 | 0.00 | USD |
| 2022 | Oculis Holding AG | 0.00 | 0.00 | USD |
| 2021 | Oculis Holding AG | 0.00 | 0.00 | USD |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Oculis Holding AG Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Oculis Holding AG | Quartalszahlen | 10.11.2025 |
| Oculis Holding AG | Quartalszahlen | 23.03.2026 |
| Oculis Holding AG | Quartalszahlen | 07.05.2026 |
| Oculis Holding AG | Quartalszahlen | 01.09.2026 |
| Oculis Holding AG | Quartalszahlen | 05.11.2026 |
Oculis Holding AG vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2025 Earnings Release | 21.08.2025 |
| Hauptversammlung | Annual General Meeting | 04.06.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 08.05.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 11.03.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 07.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 27.08.2024 |
| Hauptversammlung | Annual General Meeting | 29.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 08.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 18.03.2024 |
| Quartalszahlen | Q2 2023 Earnings Release | 29.08.2023 |
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 2 | 28 | 36 | 49 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 1 | 26 | 120 | 116 |
| Summe Anlagevermögen | 128 | 14 | 16 | 17 |
| Summe Aktiva | 128 | 40 | 136 | 133 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 8 | 146 | 25 | 52 |
| Summe Eigenkapital | 121 | -106 | 111 | 81 |
| Summe Passiva | 128 | 40 | 136 | 133 |
Adresse
| Bahnhofstrasse 20, 6300 Zug | |
| Telefon | +41 (41) 711-39-60 |
| URL | http://www.oculis.com |
Management
|
Anthony Adam Rosenberg
Chairman |
|
Arshad M. Khanani
Director |
|
Caroline Daniere
Chief Human Resources Officer |
|
Christina Maria Ackermann
Independent Non-Executive Director |
|
Geraldine O'Keeffe
Independent Director |
|
Gudrun Bachmann
Chief Technology Officer |
|
Isabelle de Chambrier
Chief Quality Officer |
|
Lionel Carnot
Independent Director |
|
Martijn Kleijwegt
Independent Director |
|
Páll Ragnar Jóhannesson
Chief Business Officer |
|
Rebecca Weil
Chief Commercial Officer |
|
Riad Sherif
Chief Executive Officer & Director |
|
Robert K. Warner
Director |
|
Sharon Klier
Chief Development Officer |
|
Snehal Shah
President-Research & Development |
|
Sylvia Cheung
Chief Financial Officer |